Texas Oncology Carrollton
Carrollton, Texas 75010
1 studies enrolling now · 5 studies all time
What they study most
Breast Cancer, Chronic Lymphocytic Leukemia (CLL), KEAP1 Gene Mutation, NFE2L2 Gene Mutation, NRF2 Mutation, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung, Non-squamous Non-small-cell Lung Cancer, Triple Negative Breast Cancer
Studies at this site
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
- Breast Cancer Index (BCI) Registry — Running, not enrolling
- Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling
- NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial — Stopped early
- informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed